A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary Sjogren's Syndrome.
Clinical trial NCT04830644 · UNKNOWN
Trial details
- NCT number
- NCT04830644
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-22
- Primary completion
- 2022-04-01
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.